Smith & Nephew Announces REGENETEN Implant Trial Data
Smith & Nephew announced compelling new randomized control trial data confirming significant outcome improvements for patients with partial-thickness rotator cuff tears treated with the Regeneten bioinductive Implant in isolation. The study, published in the Orthopaedic Journal of Sports Medicine, showed early recovery time was halved for patients returning to daily activities compared to a traditional suture anchor repair. Specifically, patients returned to driving in 2.3 weeks versus 5.1 weeks and reported a better quality of life at six weeks and three months. "We conducted a randomised controlled study of patients with symptomatic partial-thickness rotator cuff tears and found that those patients treated with the tendon sparing REGENETEN Bioinductive Implant recovered functional independence much faster than patients treated with standard surgery. Time to sling removal, return to driving, office duties, and household tasks all occurred sooner with the REGENETEN Bioinductive Implant. Importantly, these milestones were achieved without an increase in patients' pain and without compromise in rotator cuff tendon healing on 12-month MRI scans. This study marks an important shift in the evolving standard of care for partial-thickness rotator cuff tears," said Allan Wang, clinical professor of orthopedic surgery at the University of Western Australia.
